Novavax Inc (NVAX.O)

NVAX.O on Nasdaq

4.57USD
1:16pm EDT
Price Change (% chg)

$-0.03 (-0.54%)
Prev Close
$4.60
Open
$4.56
Day's High
$4.61
Day's Low
$4.51
Volume
831,857
Avg. Vol
3,951,355
52-wk High
$6.95
52-wk Low
$2.68

NVAX.O

Chart for NVAX.O

About

Novavax, Inc. (Novavax) is a clinical stage biopharmaceutical company. The Company focuses on developing recombinant vaccines. The Company’s technology platform is based on recombinant vaccine technology that includes the virus-like particles (VLPs). The Company's vaccine candidates are genetically engineered three-dimensional... (more)

Overall

Beta: 1.12
Market Cap (Mil.): $1,096.70
Shares Outstanding (Mil.): 238.41
Dividend: --
Yield (%): --

Financials

  NVAX.O Industry Sector
P/E (TTM): -- 148.68 33.74
EPS (TTM): -0.31 -- --
ROI: -37.91 -3.09 18.03
ROE: -41.54 -6.73 18.77
Search Stocks

Competitors

  Price Change
Novartis AG (NOVN.VX) CHF80.85 +0.55
Merck & Co., Inc. (MRK.N) $59.43 +0.52
Sanofi SA (SASY.PA) €79.28 -0.47
GlaxoSmithKline plc (GSK.L) 1,417.50p +5.00
AstraZeneca plc (AZN.L) 4,285.00p +46.50

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ Quantitative Report
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks